Related Experiment Video
Updated: Nov 16, 2025

Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
Taylor Morrisette1, Sara Alosaimy1, Julie V Philley2
1Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Abstract:
Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2-11.0) months. Clinical success occurred in 9/12 (75.0%) patients. Three patients experienced a possible adverse effect while on therapy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Antimicrobial Effectiveness
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD

